SLS BIO Co., Ltd (KOSDAQ:246250)

South Korea · Delayed Price · Currency is KRW

1,969.00

+85.00 (4.51%)

At close: Jun 9, 2025

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Medicine and Quality Inspection of Medicines	8.37B	Log In	Log In	Log In	Log In	Upgrade
Medicine and Quality Inspection of Medicines Growth	-7.23%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
South Korea	8.37B	Log In	Log In	Log In	Log In	Upgrade
South Korea Growth	-7.23%	Log In	Log In	Log In	Log In	Upgrade
Overseas	-	Log In	Log In	Log In	Log In	Upgrade